Lila Sciences closed a $350M Series A, bringing its total funding to $550M and securing a $1.3B+ val...
The AMW Read
Lila Sciences represents a new top-tier entrant in the bio-platform space with a $1.3B+ valuation and $350M Series A, signaling a massive capital shift toward autonomous scientific data generation.
NoveltySignificance
Healthcare & Bio · Player MapCapital Cycles
Lila Sciences closed a $350M Series A, bringing its total funding to $550M and securing a $1.3B+ valuation to pursue Scientific Superintelligence. This massive capital, backed by Nvidia, is directed entirely toward building autonomous "AI Science Factories" that merge specialized AI with robotics. The critical shift is underway: the future of discovery moves from simply analyzing existing data to actively generating proprietary scientific data through continuous, robotic experimentation.